adamantane has been researched along with Atheroma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Gao, C; Kwong, CHT; Lee, SMY; Liu, C; Wang, Q; Wang, R; Wang, Y; Xie, B | 1 |
| Liu, YS; Lu, QH; Zhang, J | 1 |
| Ametamey, SM; Borel, N; Krämer, SD; Meletta, R; Mu, L; Müller Herde, A; Rancic, Z; Schibli, R; Slavik, R | 1 |
| Hirano, T; Miyazaki, A; Mori, Y; Nagashima, M; Nohtomi, K; Terasaki, M; Watanabe, T | 1 |
4 other study(ies) available for adamantane and Atheroma
| Article | Year |
|---|---|
Cyclodextrin-mediated conjugation of macrophage and liposomes for treatment of atherosclerosis.
Topics: Adamantane; Animals; Atherosclerosis; beta-Cyclodextrins; Cholesterol; Cyclodextrins; Humans; Inflammation; Liposomes; Liver X Receptors; Macrophages; Mice; NF-E2-Related Factor 2; Plaque, Atherosclerotic; Quercetin | 2022 |
Therapeutic effects of the soluble epoxide hydrolase (sEH) inhibitor AUDA on atherosclerotic diseases.
Topics: Adamantane; Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Cytokines; Enzyme Inhibitors; Epoxide Hydrolases; In Vitro Techniques; Lauric Acids; Mice; Mice, Knockout; NF-kappa B; Plaque, Atherosclerotic; Toll-Like Receptor 4 | 2015 |
Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [
Topics: Adamantane; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Carbon Radioisotopes; Carotid Artery Diseases; Gene Expression Regulation; Humans; Male; Mice; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Quinolones; Radioactive Tracers; Receptor, Cannabinoid, CB2 | 2017 |
Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice.
Topics: Adamantane; Animals; Apolipoproteins E; Atherosclerosis; Cholesterol; Diet, Atherogenic; Dipeptidyl-Peptidase IV Inhibitors; Foam Cells; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Lipoproteins, LDL; Male; Mice; Nitriles; Plaque, Atherosclerotic; Pyrrolidines; Weight Loss | 2012 |